Cutler Group’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,000
Closed -$2K 4743
2020
Q1
$2K Buy
+1,000
New +$38.8K ﹤0.01% 3528
2017
Q1
Sell
-22,100
Closed -$50K 6987
2016
Q4
$50K Sell
22,100
-900
-4% -$43.4K ﹤0.01% 2547
2016
Q3
$56K Buy
23,000
+21,600
+1,543% +$1.09M ﹤0.01% 2351
2016
Q2
$2K Sell
1,400
-16,900
-92% -$931K ﹤0.01% 5713
2016
Q1
$11K Buy
18,300
+18,100
+9,050% +$891K ﹤0.01% 3956
2015
Q4
$1K Buy
+200
New +$9.94K ﹤0.01% 6019

Other funds holding PBH

Cutler Group's PBH Position: Q4 2017 in Review

Cutler Group sold out of Prestige Consumer Healthcare (PBH) in Q4 2017, closing a stake of 791 shares — an estimated $39K sold.

Cutler Group first reported a position in PBH in Q4 2015 and held it in 6 quarters. The position peaked at $124K in Q1 2016. 251 funds tracked by Wall St. Rank hold PBH as of Q4 2017.

  • Cutler Group reported no remaining Prestige Consumer Healthcare position as of Q4 2017 after selling out during the quarter.
  • Cutler Group sold 791 Prestige Consumer Healthcare shares in Q4 2017, an estimated $39K.
  • Cutler Group first reported a position in Prestige Consumer Healthcare in Q4 2015 and held it in 6 quarters.
  • Cutler Group's Prestige Consumer Healthcare position peaked at $124K in Q1 2016.
  • 251 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2017.

Based on Cutler Group's 13F filing for Q4 2017, filed 17 Jan 2018.